In this Viewpoint, Allison discusses discoveries involving regulation of the T-cell response, development of immune checkpoint blockade in cancer therapy, and implications of engaging the immune response as a new modality for cancer treatment.
No takes yet. Share an insight, caveat, or question.
James P. Allison (2015) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: